Tag Archives: COVID19

FDA Approves Veklury (remdesivir) for the Treatment of COVID-19

FDA Approves Veklury (remdesivir) for the Treatment of COVID-19 FOSTER CITY, Calif.–(BUSINESS WIRE)–Oct. 22, 2020– Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved the antiviral drug Veklury (remdesivir) for the treatment of patients with COVID-19 requiring hospitalization. As an antiviral drug, Veklury works to stop replication… Read More »

Will Trump, Congressional Infections Boost Innovations For Covid-19 Survivors?

By MICHAEL MILLENSON When powerful politicians confront a life-threatening diagnosis, it can change policy priorities.  In addition to President Trump and a slew of top aides, five U.S. senators and 15 members of the House of Representatives have now tested positive or been presumed positive in tests for Covid-19 as of Oct. 5, according to… Read More »

Vouchers to boost SA tourism amid COVID-19

Accommodation vouchers are being offered to boost tourism across South Australia during the COVID-19 pandemic but the state opposition says they’re too limited. The Great State vouchers, which became available from Thursday, offer $ 100 off accommodation in Adelaide and $ 50 off in regional centres, provided travellers are staying at participating venues. Premier Steven… Read More »

Eli Lilly taps Fujifilm to chip in on COVID-19 antibody manufacturing as it awaits FDA’s emergency use decision

Shortly after rolling out interim data on its COVID-19 antibody hopeful, Eli Lilly last week sent the therapy ahead to the FDA for a potential emergency nod. If the antibody crosses the finish line, Lilly can expect a huge surge in demand—and it’s bringing in a manufacturing partner to help out.  Lilly has signed on… Read More »